Sanofi SNY announced that the FDA has accepted a regulatory filing seeking to expand the use of its type 1 diabetes (T1D) drug, Tzield (teplizumab), in individuals aged one year and older. The agency ...

Abstract: A novel frequency response range expanded slope-assisted Brillouin optical time domain analysis (SA-BOTDA) sensor is proposed and demonstrated using randomized sampling technique. In ...